Karyopharm Therapeutics I... (KPTI)
Karyopharm Therapeutics Max Pain By Strike
KPTI trades at $5.96, 19.2% above the near-term max pain of $5 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$7.5), signaling increased put positioning or downside protection. Key magnetic zone at 5 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Karyopharm Therapeutics Max Pain By Expiry
Max pain for KPTI shows a downward trend from 7.5 to 2.5, indicating bearish sentiment or hedging activity. The 91% spread signals divergent expectations across timeframes. Levels distributed around 5.96. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 5 | -0.96 (-16.11%) |
| Sep 19, 2025 | 7.5 | 1.54 (25.84%) |
| Oct 17, 2025 | 2.5 | -3.46 (-58.05%) |
| Nov 21, 2025 | 7.5 | 1.54 (25.84%) |
| Feb 20, 2026 | 5 | -0.96 (-16.11%) |